These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 32105310)
1. Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study. Reinisch W; Panaccione R; Bossuyt P; Baert F; Armuzzi A; Hébuterne X; Travis S; Danese S; Sandborn WJ; Schreiber S; Berg S; Zhou Q; Kligys K; Neimark E; Suleiman AA; D'Haens G; Colombel JF Inflamm Bowel Dis; 2020 Sep; 26(10):1562-1571. PubMed ID: 32105310 [TBL] [Abstract][Full Text] [Related]
2. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease. Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085 [TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients. Lin WC; Wong JM; Tung CC; Lin CP; Chou JW; Wang HY; Shieh MJ; Chang CH; Liu HH; Wei SC; World J Gastroenterol; 2015 Dec; 21(48):13566-73. PubMed ID: 26730169 [TBL] [Abstract][Full Text] [Related]
4. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin. Zubin G; Peter L Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564 [TBL] [Abstract][Full Text] [Related]
5. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866 [TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969 [TBL] [Abstract][Full Text] [Related]
7. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670 [TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983 [TBL] [Abstract][Full Text] [Related]
10. Serum calprotectin as a biomarker for Crohn's disease. Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E; J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins. D'Haens G; Kelly O; Battat R; Silverberg MS; Laharie D; Louis E; Savarino E; Bodini G; Yarur A; Boland BS; Afif W; Li XJ; Hale M; Ho J; Kondragunta V; Huang B; Kuy C; Okada L; Hester KD; Bray KR; Mimms L; Jain A; Singh S; Collins A; Valasek MA; Sandborn WJ; Vermeire S; Dulai PS Gastroenterology; 2020 Feb; 158(3):515-526.e10. PubMed ID: 31711925 [TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660 [TBL] [Abstract][Full Text] [Related]
15. Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohn's Disease. Garcia-Planella E; Mañosa M; Cabré E; Marín L; Gordillo J; Zabana Y; Boix J; Sáinz S; Domènech E Inflamm Bowel Dis; 2016 Dec; 22(12):2879-2885. PubMed ID: 27824646 [TBL] [Abstract][Full Text] [Related]
16. Impact of disease location on fecal calprotectin levels in Crohn's disease. Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819 [TBL] [Abstract][Full Text] [Related]
17. Combined evaluation of biomarkers as predictor of maintained remission in Crohn's disease. Sollelis E; Quinard RM; Bouguen G; Goutte M; Goutorbe F; Bouvier D; Pereira B; Bommelaer G; Buisson A World J Gastroenterol; 2019 May; 25(19):2354-2364. PubMed ID: 31148906 [TBL] [Abstract][Full Text] [Related]
18. Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy. Engström J; Lönnkvist M; Befrits R; Ljung T; Diaz-Tartera H; Holst M; Hellström PM Scand J Gastroenterol; 2019 Sep; 54(9):1081-1088. PubMed ID: 31499013 [No Abstract] [Full Text] [Related]
19. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ; Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314 [TBL] [Abstract][Full Text] [Related]